WO2008136548A1 - Device of measuring and monitoring a hemoglobin value through blood tube - Google Patents

Device of measuring and monitoring a hemoglobin value through blood tube Download PDF

Info

Publication number
WO2008136548A1
WO2008136548A1 PCT/KR2007/002237 KR2007002237W WO2008136548A1 WO 2008136548 A1 WO2008136548 A1 WO 2008136548A1 KR 2007002237 W KR2007002237 W KR 2007002237W WO 2008136548 A1 WO2008136548 A1 WO 2008136548A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
light
probe
blood tube
value
Prior art date
Application number
PCT/KR2007/002237
Other languages
French (fr)
Inventor
Dong-Soo Kim
Byeong-Whan Kim
Young-Wook Keum
Original Assignee
Jsm Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsm Healthcare Inc filed Critical Jsm Healthcare Inc
Priority to PCT/KR2007/002237 priority Critical patent/WO2008136548A1/en
Publication of WO2008136548A1 publication Critical patent/WO2008136548A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N21/3151—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using two sources of radiation of different wavelengths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14535—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14557—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted to extracorporeal circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607—Regulation parameters
    • A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00—Features of devices classified in G01N21/00
    • G01N2201/06—Illumination; Optics
    • G01N2201/062—LED's

Definitions

  • the present invention relates to devices for measuring and monitoring hemoglobin value through blood tube, and more particularly, to a device for measuring and monitoring hemoglobin value called 'hematocrit' indicating blood concentration, which is mounted on a blood tube of a hemodialysis device that induces cardiopulmonary bypass of blood of a patient and dialyzes the blood.
  • a flexible blood tube is generally used to carry out the cardiopulmonary bypass.
  • Such blood tube principally comprises: an arterial blood tube equipped with an artery puncturing needle at front end of the tube, which draws out blood from a patient; a venous blood tube equipped with a vein puncturing needle at front end of the tube, which returns the blood to the patient; and, additionally, a dialyzer interposed between the arterial blood tube and the venous blood tube.
  • a scrubbing tube type blood pump is fixed and driven to draw out the blood from the artery puncturing needle and induce the cardiopulmonary bypass of the blood from arterial blood line to venous blood line through the dialyzer.
  • the dialyzer is provided with a plurality of hollow fibers, through which the blood passes.
  • a housing body of the dialyzer has a dialysis solution input port and a dialysis solution output port in a protrusion form to be connected with the hemodialysis device.
  • a dialysis solution with constant concentration is introduced from the hemodialysis device through the dialysis solution input port into the dialyzer while the dialysis solution passes through outer part of the hollow fibers (that is, between outer sides of the hollow fibers and inner circumference of the housing body), then, is exhausted from the dialyzer through the dialysis solution output port.
  • the hollow fibers have microfine pores formed on walls of the fibers to create a blood purification membrane, waste substances of the blood pass through inner parts of the hollow fibers and through the membrane, followed by flowing into the dialysis solution while the purified blood free of the waste substances returns into body of the patient.
  • the dialysis device is equipped with a water removal pump to remove water moiety from the blood during dialysis treatment.
  • water removal rate amount of water moiety to be removed
  • water removal pump When the water moiety is removed from the blood, amount of water moiety to be removed (that is, water removal rate) is varied by controlling the water removal pump. Rapid or excessive water removal reduces amount of blood circulation too much, thus, may result in blood reduction or cause shock to the patient.
  • the water removal rate is too low, whole time for dialysis treatment is increased and may be too demanding for the patient.
  • Hematocrit value is an indicator of concentration of blood and means a ratio by volume of red blood cells with respect to whole volume of the blood.
  • Hematocrit value during water removal usually ranges from 10 to 60%. However, in case that the patient undergoes reduction of blood pressure or experiences symptoms of shock, the hematocrit value tends to be higher than desirable level. Accordingly, when the patient is subjected to the dialysis treatment, the treatment can be conducted with an appropriate water removal rate which causes minimal burden to the patient by monitoring this parameter (that is, hematocrit value) in real time during the water removal and controlling the water removal pump. Such hematocrit value is determined by specific instruments called hematocrit sensors or probes.
  • the hematocrit sensor or probe generally has construction of a light emitting device and a light receiving device opposite each other across a flexible blood tube, which detects light received by the light receiving device after irradiating the light from the light emitting device and measures light transmissivity of the blood, thereby estimating the hematocrit value based on the measured amount.
  • the blood tube since most of conventional hematocrit sensors have adopted the light transmission mode with construction of the light emitting device and the light receiving device opposite each other across the blood tube, the blood tube must be interposed or fitted between the light emitting device and the light receiving device in order to determine the hematocrit value, thereby causing deformation of the blood tube.
  • the blood tube should be strongly or forcedly fitted and supported between both of the devices in order to improve measurement accuracy or precision.
  • such strong fitting force may cause deformation of the flexible blood tube, leading to reduction of flow rate of the blood and great stress or load applied to the blood tube.
  • Korean Patent Laid-Open No. 2005-25299 disclosed a light reflection type hematocrit sensor that has a light emitting device and a light receiving device positioned at the same side of a blood tube, instead of arranging both of the devices to be opposed to each other, so that the light receiving device receives only the reflected light.
  • known instruments for measuring hemoglobin (that is, hematocrit) value described above have a limit in more precisely determining or correctly identifying the hemoglobin value because the instruments receive only one selected from transmitted light or reflected light after irradiating light from just one among various kinds of light sources.
  • an object of the present invention is to provide a device for measuring and monitoring hemoglobin value, characterized in that the device irradiates light from two light sources with different wavelengths to blood passing through a blood tube of a hemodialysis device, digitizes detected signals for transmitted light and reflected light resulting from the irradiation, and determines hemoglobin value by linear assembly of the digital results.
  • the device for measuring and monitoring hemoglobin value according to the present invention is an ideal combination of typical transmission form and reflection form to more precisely determine the hemoglobin value by way of non-invasive technique.
  • Another object of the present invention is to provide an apparatus for displaying the measured hemoglobin value by indicating the hemoglobin value on monitoring desks through wireless communication.
  • the present invention provides a device for measuring and monitoring hemoglobin value through blood tube, comprising: (I) a probe 1 mounted on a blood tube of a hemodialysis device to purify blood of a patient while carrying out cardiopulmonary bypass of the blood, which irradiates light from two light sources with different wavelengths to the blood passing through the blood tube in non-invasive mode, digitizes detected signals for transmitted light and reflected light for each of the wavelengths resulting from the irradiation, and transfers the digitized results (that is, digital signals) to a main device 3; and (II) the main device 3 which receives the digital signals from the probe 1, estimates hemoglobin value through a linear assembly of data for transmitted light and reflected light for each of wavelengths in relative ratios thereof by using the received digital signals, processes the estimated value, and on-line displays the results.
  • Fig. 1 is a schematic view illustrating the present inventive device.
  • the probe 1 comprises: a groove Ib for fitting the blood tube 2; a sliding lid Ia for covering and fixing the fitted blood tube 2; two emitting units Ic and Id to be directly in contact with the fitted blood tube 2; first light receiving unit Ie for receiving reflected light; second light receiving unit If for receiving transmitted light; an amplifier Ig for amplifying signals; and an ADC Ih for converting analog signals into digital signals.
  • Fig. 2 is a schematic perspective view illustrating the probe 1 according to the present invention.
  • Fig. 3 is a schematic perspective view illustrating the probe 1 having the blood tube 2 fitted into the probe.
  • Fig. 4 is a schematically cross-sectional view illustrating the probe 1 , which is cut in longitudinal direction of the probe shown in Fig. 3.
  • Fig. 5 is a schematically cross- sectional view illustrating the probe 1 , which is cut in horizontal direction of the probe shown in Fig. 3.
  • the emitting units Ic and Id and the first light receiving unit Ie for receiving the reflected light are arranged in series at one side of the blood tube 2, while the second light receiving unit If is located at the other side of the blood tube 2.
  • the light sources used for irradiating light from the emitting units Ic and Id mounted on the probe 1 are preferably LED at 570nm and LED at 805nm, respectively.
  • Absorbency of oxidized hemoglobin and absorbency of reduced hemoglobin are matched to LED at 570nm and LED at 805nm, respectively. Also, the first light receiving unit Ie and the second light receiving unit If are preferably photodiodes.
  • the main device 3 is provided with CPU 3b for controlling the probe 1 and processing input data, a display 3a for indicating hemoglobin value, and a wireless communication module 3c.
  • Fig. 6 is a schematic view illustrating the main device 3 according to the present invention.
  • the wireless communication module 3c on-line transmits the measured hemoglobin value, especially, hematocrit value to a monitoring desk 4 which is usually used by nurses.
  • First LED at 570nm and second LED at 805nm used for irradiating light from the emitting units Ic and Id are controlled as shown in Fig. 7, so that LEDs are alternately used to irradiate light at constant intervals by CPU 3b of the main device connected to the LEDs through a connector 5.
  • Fig. 7 is a schematic view illustrating that the light sources are controlled to irradiate light in turns at the constant intervals, in particular, A shows a region of detecting the reflected light and the transmitted light for LED at 570nm while B shows another region of detecting the reflected light and the transmitted light for LED at 805nm.
  • the present invention can improve accuracy of measuring the hemoglobin value by linearly assembling detected values in relative ratios of the reflected light and the transmitted light detected at two wavelengths of 570nm and 805nm and numerically representing the assembled results.
  • a R (- ⁇ 570' -* 570 ) ' ( ⁇ 805' ⁇ 8Os)
  • Hb ⁇ R + K ⁇ T (K: proportionality constant) (ADVANTAGEOUS EFFECTS)
  • the present invention can more precisely measure hemoglobin value in blood during hemodialysis and on-line display the measured hemoglobin value on a main device and a monitoring desk. Consequently, the present invention has beneficial features such as effective preventative treatment for anemia during the hemodialysis and removal of need for biochemical blood test which is typically applied to patients requiring the hemodialysis.
  • Fig. 1 is a schematic view illustrating the present inventive device
  • Fig. 2 is a schematic perspective view illustrating the probe 1 of the device according to the present invention
  • Fig. 3 is a schematic perspective view illustrating the probe 1 having the blood tube 2 fitted into the probe;
  • Fig. 4 is a schematically cross-sectional view illustrating the probe, which is cut in longitudinal direction of the probe shown in Fig. 3
  • Fig. 5 is a schematically cross-sectional view illustrating the probe, which is cut in horizontal direction of the probe shown in Fig. 3;
  • Fig. 6 is a schematic view illustrating the main device 3 of the device according to the present invention
  • Fig. 7 is a schematic view illustrating that light sources are controlled to irradiate light in turns at the constant intervals by two emitting units Ic and Id.
  • Ib groove for fitting blood tube
  • Ic first emitting unit
  • Ih ADC Ig: signal amplifier Ij: PCB 3a: display
  • A region for detecting reflected light and transmitted light for irradiated light at 570nm
  • B region for detecting reflected light and transmitted light for irradiated light at 805nm
  • the present invention is effective to measure constitutional ingredients of blood during hemodialysis by way of non-invasive mode and monitor the result by applying the device of the present invention to a conventional hemodialysis device.

Abstract

Disclosed is a device for measuring and monitoring hemoglobin (hematocrit) value through blood tube, more particularly, a device comprising: (I) a probe 1 mounted on a blood tube of a hemodialysis device to purify blood of a patient while carrying out cardiopulmonary bypass of the blood, which irradiates light from two light sources with different wavelengths to the blood passing through the blood tube in non-invasive mode, digitizes detected signals for transmitted light and reflected light for each of the wavelengths resulting from the irradiation, and transfers the digitized results, that is, digital signals to a main device 3; and (II) the main device 3 which receives the digital signals from the probe 1, estimates hemoglobin value through a linear assembly of data for transmitted light and reflected light for each of wavelengths in relative ratios thereof by using the received digital signals, processes the estimated value, and on-line displays the results. The present invention can more precisely measure hemoglobin value in blood during hemodialysis and on-line display the measured hemoglobin value, prevent deformation of the flexible blood tube, and reduce size of the probe.

Description

DEVICE OF MEASURING AND MONITORING A HEMOGLOBIN VALUE
THROUGH BLOOD TUBE
TECHNICAL FIELD The present invention relates to devices for measuring and monitoring hemoglobin value through blood tube, and more particularly, to a device for measuring and monitoring hemoglobin value called 'hematocrit' indicating blood concentration, which is mounted on a blood tube of a hemodialysis device that induces cardiopulmonary bypass of blood of a patient and dialyzes the blood.
For typical dialysis treatment, a flexible blood tube is generally used to carry out the cardiopulmonary bypass. Such blood tube principally comprises: an arterial blood tube equipped with an artery puncturing needle at front end of the tube, which draws out blood from a patient; a venous blood tube equipped with a vein puncturing needle at front end of the tube, which returns the blood to the patient; and, additionally, a dialyzer interposed between the arterial blood tube and the venous blood tube. To the arterial blood tube, a scrubbing tube type blood pump is fixed and driven to draw out the blood from the artery puncturing needle and induce the cardiopulmonary bypass of the blood from arterial blood line to venous blood line through the dialyzer. The dialyzer is provided with a plurality of hollow fibers, through which the blood passes. A housing body of the dialyzer has a dialysis solution input port and a dialysis solution output port in a protrusion form to be connected with the hemodialysis device. A dialysis solution with constant concentration is introduced from the hemodialysis device through the dialysis solution input port into the dialyzer while the dialysis solution passes through outer part of the hollow fibers (that is, between outer sides of the hollow fibers and inner circumference of the housing body), then, is exhausted from the dialyzer through the dialysis solution output port. Since the hollow fibers have microfine pores formed on walls of the fibers to create a blood purification membrane, waste substances of the blood pass through inner parts of the hollow fibers and through the membrane, followed by flowing into the dialysis solution while the purified blood free of the waste substances returns into body of the patient. In this case, the dialysis device is equipped with a water removal pump to remove water moiety from the blood during dialysis treatment.
When the water moiety is removed from the blood, amount of water moiety to be removed (that is, water removal rate) is varied by controlling the water removal pump. Rapid or excessive water removal reduces amount of blood circulation too much, thus, may result in blood reduction or cause shock to the patient. On the other hand, if the water removal rate is too low, whole time for dialysis treatment is increased and may be too demanding for the patient.
BACKGROUND ART
Under the circumstance, some techniques for controlling water removal rate while monitoring blood condition of patients have been proposed in, for example, Japanese Patent Laid-Open No. Hl 1-221275 and Japanese Patent Laid-Open No.2001-000540. According to such prior arts, one of parameters indicating the blood condition of a patient is hematocrit value. Hematocrit value is an indicator of concentration of blood and means a ratio by volume of red blood cells with respect to whole volume of the blood.
Hematocrit value during water removal usually ranges from 10 to 60%. However, in case that the patient undergoes reduction of blood pressure or experiences symptoms of shock, the hematocrit value tends to be higher than desirable level. Accordingly, when the patient is subjected to the dialysis treatment, the treatment can be conducted with an appropriate water removal rate which causes minimal burden to the patient by monitoring this parameter (that is, hematocrit value) in real time during the water removal and controlling the water removal pump. Such hematocrit value is determined by specific instruments called hematocrit sensors or probes. The hematocrit sensor or probe generally has construction of a light emitting device and a light receiving device opposite each other across a flexible blood tube, which detects light received by the light receiving device after irradiating the light from the light emitting device and measures light transmissivity of the blood, thereby estimating the hematocrit value based on the measured amount. However, since most of conventional hematocrit sensors have adopted the light transmission mode with construction of the light emitting device and the light receiving device opposite each other across the blood tube, the blood tube must be interposed or fitted between the light emitting device and the light receiving device in order to determine the hematocrit value, thereby causing deformation of the blood tube. In other words, in case of the light transmission type sensor, the blood tube should be strongly or forcedly fitted and supported between both of the devices in order to improve measurement accuracy or precision. Herein, such strong fitting force may cause deformation of the flexible blood tube, leading to reduction of flow rate of the blood and great stress or load applied to the blood tube.
Furthermore, a housing body enclosing the light emitting device and alternative housing body enclosing the light receiving device are separately manufactured then integrated together to form a sensor assembly of some size. Therefore, the known hematocrit sensors certainly have a difficulty in management of such large sensor assembly. In order to solve the above problem, Korean Patent Laid-Open No. 2005-25299 disclosed a light reflection type hematocrit sensor that has a light emitting device and a light receiving device positioned at the same side of a blood tube, instead of arranging both of the devices to be opposed to each other, so that the light receiving device receives only the reflected light. But, known instruments for measuring hemoglobin (that is, hematocrit) value described above have a limit in more precisely determining or correctly identifying the hemoglobin value because the instruments receive only one selected from transmitted light or reflected light after irradiating light from just one among various kinds of light sources.
DISCLOSURE OF THE INVENTION (TECHNICAL PROBLEM)
Accordingly, the present invention is directed to solve the problems of conventional instruments as described above and, an object of the present invention is to provide a device for measuring and monitoring hemoglobin value, characterized in that the device irradiates light from two light sources with different wavelengths to blood passing through a blood tube of a hemodialysis device, digitizes detected signals for transmitted light and reflected light resulting from the irradiation, and determines hemoglobin value by linear assembly of the digital results. Briefly, the device for measuring and monitoring hemoglobin value according to the present invention is an ideal combination of typical transmission form and reflection form to more precisely determine the hemoglobin value by way of non-invasive technique.
Another object of the present invention is to provide an apparatus for displaying the measured hemoglobin value by indicating the hemoglobin value on monitoring desks through wireless communication.
(TECHNICAL MEANS TO SOLVE THE PROBLEM)
Hereinafter, the present invention will be described in detail below with reference to the accompanying drawings.
As shown in Fig. 1, the present invention provides a device for measuring and monitoring hemoglobin value through blood tube, comprising: (I) a probe 1 mounted on a blood tube of a hemodialysis device to purify blood of a patient while carrying out cardiopulmonary bypass of the blood, which irradiates light from two light sources with different wavelengths to the blood passing through the blood tube in non-invasive mode, digitizes detected signals for transmitted light and reflected light for each of the wavelengths resulting from the irradiation, and transfers the digitized results (that is, digital signals) to a main device 3; and (II) the main device 3 which receives the digital signals from the probe 1, estimates hemoglobin value through a linear assembly of data for transmitted light and reflected light for each of wavelengths in relative ratios thereof by using the received digital signals, processes the estimated value, and on-line displays the results.
Fig. 1 is a schematic view illustrating the present inventive device.
As illustrated in Fig. 2 to Fig. 5, the probe 1 comprises: a groove Ib for fitting the blood tube 2; a sliding lid Ia for covering and fixing the fitted blood tube 2; two emitting units Ic and Id to be directly in contact with the fitted blood tube 2; first light receiving unit Ie for receiving reflected light; second light receiving unit If for receiving transmitted light; an amplifier Ig for amplifying signals; and an ADC Ih for converting analog signals into digital signals.
Fig. 2 is a schematic perspective view illustrating the probe 1 according to the present invention. Fig. 3 is a schematic perspective view illustrating the probe 1 having the blood tube 2 fitted into the probe. Fig. 4 is a schematically cross-sectional view illustrating the probe 1 , which is cut in longitudinal direction of the probe shown in Fig. 3. Fig. 5 is a schematically cross- sectional view illustrating the probe 1 , which is cut in horizontal direction of the probe shown in Fig. 3.
As illustrated in Fig. 5, the emitting units Ic and Id and the first light receiving unit Ie for receiving the reflected light are arranged in series at one side of the blood tube 2, while the second light receiving unit If is located at the other side of the blood tube 2. The light sources used for irradiating light from the emitting units Ic and Id mounted on the probe 1 are preferably LED at 570nm and LED at 805nm, respectively.
Absorbency of oxidized hemoglobin and absorbency of reduced hemoglobin are matched to LED at 570nm and LED at 805nm, respectively. Also, the first light receiving unit Ie and the second light receiving unit If are preferably photodiodes.
As shown in Fig. 6, the main device 3 is provided with CPU 3b for controlling the probe 1 and processing input data, a display 3a for indicating hemoglobin value, and a wireless communication module 3c. Fig. 6 is a schematic view illustrating the main device 3 according to the present invention.
The wireless communication module 3c on-line transmits the measured hemoglobin value, especially, hematocrit value to a monitoring desk 4 which is usually used by nurses.
First LED at 570nm and second LED at 805nm used for irradiating light from the emitting units Ic and Id are controlled as shown in Fig. 7, so that LEDs are alternately used to irradiate light at constant intervals by CPU 3b of the main device connected to the LEDs through a connector 5.
Fig. 7 is a schematic view illustrating that the light sources are controlled to irradiate light in turns at the constant intervals, in particular, A shows a region of detecting the reflected light and the transmitted light for LED at 570nm while B shows another region of detecting the reflected light and the transmitted light for LED at 805nm.
The present invention can improve accuracy of measuring the hemoglobin value by linearly assembling detected values in relative ratios of the reflected light and the transmitted light detected at two wavelengths of 570nm and 805nm and numerically representing the assembled results.
Numerical Algorithm used in the present invention is as follows:
(1) Calculation of ratio of reflected light Rs70(i) inputted in the first photodiode to irradiated light Is70(i) of first LED at 570nm: Rs70(i) / l570(l);
(2) Calculation of ratio of transmitted light Ts70(i) inputted in the second photodiode to irradiated light Is70(i) of first LED at 570nm:
T570(l) / l570(l)|
(3) Calculation of ratio of reflected light Rso5(i) inputted in the first photodiode to irradiated light Iso5(i) of second LED at 805nm: Rso5(i)
/ l805(l)| (4) Calculation of ratio of transmitted light Tso5(i) inputted in the second photodiode to irradiated light Iso5(i) of second LED at 805nm:
TδO5(l) / 1805(1);
(5) Calculation of ratio of reflected light to irradiated light (Rδ70(2) / 1570(2); Rβo5(2) / 1805(2) ) and ratio of transmitted light to irradiated light (T570(2) / Ϊ570(2); Tso5(2) / 1805(2) ), at each of the wavelengths by- irradiating light from the first LED at 570nm and the second LED at 805nm;
(6) Calculation of average value for the ratios of reflected light to irradiated light;
Figure imgf000011_0001
(7) Calculation of a ratio ΔR of reflected light at 570nm to reflected light at 805nm;
A R = (-^ 570' -* 570 ) ' ( ^ 805' ^8Os)
(8) Calculation of average value for the ratios of transmitted light to irradiated light;
570/ww : — — = ( r570(1)//570(1)+ 7'570(2)/ 1570(2) V^
1 570' l 570
V^
Figure imgf000011_0002
(9) Calculation of a ratio ΛT of transmitted light at 570nm to reflected light at 805nm;
Figure imgf000011_0003
(10) Calculation of compensated hematocrit value Hb by using a linear assembly of ratios of the reflected light and the transmitted light.
Hb = ΔR + K ΔT (K: proportionality constant) (ADVANTAGEOUS EFFECTS)
As described in detail above, the present invention can more precisely measure hemoglobin value in blood during hemodialysis and on-line display the measured hemoglobin value on a main device and a monitoring desk. Consequently, the present invention has beneficial features such as effective preventative treatment for anemia during the hemodialysis and removal of need for biochemical blood test which is typically applied to patients requiring the hemodialysis.
BRIEF DESCRIPTION OF THE DRAWINGS
The above objects, features and advantages of the present invention will become more apparent to those skilled in the related art in conjunction with the accompanying drawings.
Fig. 1 is a schematic view illustrating the present inventive device;
Fig. 2 is a schematic perspective view illustrating the probe 1 of the device according to the present invention; Fig. 3 is a schematic perspective view illustrating the probe 1 having the blood tube 2 fitted into the probe;
Fig. 4 is a schematically cross-sectional view illustrating the probe, which is cut in longitudinal direction of the probe shown in Fig. 3; Fig. 5 is a schematically cross-sectional view illustrating the probe, which is cut in horizontal direction of the probe shown in Fig. 3;
Fig. 6 is a schematic view illustrating the main device 3 of the device according to the present invention; and Fig. 7 is a schematic view illustrating that light sources are controlled to irradiate light in turns at the constant intervals by two emitting units Ic and Id.
[Description of symbols for major parts in drawings] 1 : probe 2: blood tube
3: main device 4: monitoring desk
5: connector 6: adaptor
7: supporter Ia: sliding lid
Ib: groove for fitting blood tube Ic: first emitting unit
Id: second emitting unit
Ie: first light receiving unit
If: second light receiving unit
Ih: ADC Ig: signal amplifier Ij: PCB 3a: display
3b: CPU
3c: wireless communication module
A: region for detecting reflected light and transmitted light for irradiated light at 570nm B: region for detecting reflected light and transmitted light for irradiated light at 805nm INDUSTRIAL APPLICABILITY
As described in detail above, the present invention is effective to measure constitutional ingredients of blood during hemodialysis by way of non-invasive mode and monitor the result by applying the device of the present invention to a conventional hemodialysis device.
While the present invention has been described with reference to the accompanying drawings, it will be understood by those skilled in the art that various modifications and variations may be made therein without departing from the scope of the present invention as defined by the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A device for measuring and monitoring hemoglobin value through blood tube, comprising: (I) a probe 1 mounted on a blood tube of a hemodialysis device to purify blood of a patient while carrying out cardiopulmonary bypass of the blood, which irradiates light from two light sources with different wavelengths to the blood passing through the blood tube in non-invasive mode, digitizes detected signals for transmitted light and reflected light for each of the wavelengths resulting from the irradiation, and transfers the digitized results, that is, digital signals to a main device 3; and (II) the main device 3 which receives the digital signals from the probe 1, estimates hemoglobin value through a linear assembly of data for transmitted light and reflected light for each of wavelengths in relative ratios thereof by using the received digital signals, processes the estimated value, and on-line displays the results.
2. The device according to Claim 1, wherein the probe 1 includes: a groove Ib for fitting the blood tube 2; a sliding lid Ia for covering and fixing the fitted blood tube 2; two emitting units Ic and Id to be directly in contact with the fitted blood tube 2; a first light receiving unit Ie for receiving reflected light; a second light receiving unit If for receiving transmitted light; an amplifier Ig for amplifying signals; and an ADC Ih for converting analog signals into digital signals.
3. The device according to Claim 1, wherein the main device 3 is provided with a CPU 3b for controlling the probe 1 and processing input data, a display 3a for indicating hemoglobin value, and a wireless communication module 3c.
4. The device according to Claim 1, wherein the two light sources in the probe 1 are LED at 570nm and LED at 805nm, respectively.
5. The device according to Claim 2, wherein the first light receiving unit Ie and the second light receiving unit If are photodiodes, respectively.
PCT/KR2007/002237 2007-05-07 2007-05-07 Device of measuring and monitoring a hemoglobin value through blood tube WO2008136548A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/KR2007/002237 WO2008136548A1 (en) 2007-05-07 2007-05-07 Device of measuring and monitoring a hemoglobin value through blood tube

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2007/002237 WO2008136548A1 (en) 2007-05-07 2007-05-07 Device of measuring and monitoring a hemoglobin value through blood tube

Publications (1)

Publication Number Publication Date
WO2008136548A1 true WO2008136548A1 (en) 2008-11-13

Family

ID=39943649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/002237 WO2008136548A1 (en) 2007-05-07 2007-05-07 Device of measuring and monitoring a hemoglobin value through blood tube

Country Status (1)

Country Link
WO (1) WO2008136548A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2510958A1 (en) * 2011-04-11 2012-10-17 Fresenius Medical Care Deutschland GmbH Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration and/or peritoneal dialysis
EP2434952B1 (en) * 2009-05-26 2017-01-11 B. Braun Avitum AG Apparatus and method for spectrophotometric measurements of blood parameters
WO2022008850A1 (en) * 2020-07-08 2022-01-13 I-Sep Device and method for determining the haemoglobin or haematocrit level of a flowing liquid
FR3112390A1 (en) * 2020-07-08 2022-01-14 I Sep Apparatus for determining the hemoglobin or hematocrit level of a circulating fluid

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5331958A (en) * 1992-03-31 1994-07-26 University Of Manitoba Spectrophotometric blood analysis
US5351686A (en) * 1990-10-06 1994-10-04 In-Line Diagnostics Corporation Disposable extracorporeal conduit for blood constituent monitoring
US5601080A (en) * 1994-12-28 1997-02-11 Coretech Medical Technologies Corporation Spectrophotometric blood analysis
US6493567B1 (en) * 1997-10-14 2002-12-10 Transonic Systems, Inc. Single light sensor optical probe for monitoring blood parameters and cardiovascular measurements
US20030009090A1 (en) * 2001-04-19 2003-01-09 Jeon Kye-Jin Method and apparatus for noninvasively monitoring hemoglobin concentration and oxygen saturation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5351686A (en) * 1990-10-06 1994-10-04 In-Line Diagnostics Corporation Disposable extracorporeal conduit for blood constituent monitoring
US5331958A (en) * 1992-03-31 1994-07-26 University Of Manitoba Spectrophotometric blood analysis
US5601080A (en) * 1994-12-28 1997-02-11 Coretech Medical Technologies Corporation Spectrophotometric blood analysis
US6493567B1 (en) * 1997-10-14 2002-12-10 Transonic Systems, Inc. Single light sensor optical probe for monitoring blood parameters and cardiovascular measurements
US20030009090A1 (en) * 2001-04-19 2003-01-09 Jeon Kye-Jin Method and apparatus for noninvasively monitoring hemoglobin concentration and oxygen saturation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2434952B1 (en) * 2009-05-26 2017-01-11 B. Braun Avitum AG Apparatus and method for spectrophotometric measurements of blood parameters
EP2510958A1 (en) * 2011-04-11 2012-10-17 Fresenius Medical Care Deutschland GmbH Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration and/or peritoneal dialysis
WO2012140022A1 (en) * 2011-04-11 2012-10-18 Fresenius Medical Care Deutschland Gmbh Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration, and/or peritoneal dialysis
EP2510958B1 (en) 2011-04-11 2015-07-22 Fresenius Medical Care Deutschland GmbH Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration and/or peritoneal dialysis
US9215985B2 (en) 2011-04-11 2015-12-22 Fresenius Medical Care Deutschland Gmbh Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration, and/or peritoneal dialysis
EA027703B1 (en) * 2011-04-11 2017-08-31 Фрезениус Медикл Кэа Дойчланд Гмбх Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration, and/or peritoneal dialysis
WO2022008850A1 (en) * 2020-07-08 2022-01-13 I-Sep Device and method for determining the haemoglobin or haematocrit level of a flowing liquid
FR3112390A1 (en) * 2020-07-08 2022-01-14 I Sep Apparatus for determining the hemoglobin or hematocrit level of a circulating fluid

Similar Documents

Publication Publication Date Title
US9173988B2 (en) Sensor clip assembly for an optical monitoring system
KR100313211B1 (en) Disposable extracorporeal catheter for observing blood components
US7537688B2 (en) Blood purification device
US6931268B1 (en) Active pulse blood constituent monitoring
CA2817148C (en) Sensor clip assembly for an optical monitoring system
JP4925159B2 (en) Blood purification equipment
US7381195B2 (en) Hematocrit sensor
JP6851996B2 (en) Direct light difference measurement system
US9849225B2 (en) Self calibrating blood chamber
US8517968B2 (en) Shrouded sensor clip assembly and blood chamber for an optical blood monitoring system
US20060047193A1 (en) Method and device for determining blood volume during an extracorporeal blood treatment
CN102426159B (en) Device for measuring blood component concentration and method for measuring blood component concentration
CA2808252A1 (en) Blood chamber for an optical blood monitoring system
WO2006137228A1 (en) Apparatus for dialytic therapy
WO2008136548A1 (en) Device of measuring and monitoring a hemoglobin value through blood tube
US20080103427A1 (en) Blood purification device
US8870769B2 (en) Inter dialytic monitoring device
JP6728043B2 (en) Method and apparatus for determining a correction factor for detecting hemolysis or for correcting the effect of hemolysis in hematocrit measurement
JP5222706B2 (en) Blood purification apparatus and blood flow calculation method thereof
WO2012127422A1 (en) Device for the extracorporeal monitoring of blood
JP5438939B2 (en) Blood purification equipment
KR100812249B1 (en) Device of measuring and monitoring a hemoglobin value through blood tube
CA2780871C (en) Self-flowing measuring system
JP4936436B2 (en) Blood purification apparatus and method for determining mounting position of blood concentration detecting means thereof
CN213993572U (en) Device with blood pH value monitoring function

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07746392

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07746392

Country of ref document: EP

Kind code of ref document: A1